| Primary |
| Factor Viii Deficiency |
44.3% |
| Haemophilia |
15.6% |
| Product Used For Unknown Indication |
12.6% |
| Drug Use For Unknown Indication |
7.2% |
| Haemarthrosis |
6.0% |
| Prophylaxis |
4.2% |
| Traumatic Haemorrhage |
3.6% |
| Haemorrhage |
1.2% |
| Hypertension |
1.2% |
| Cerebral Haemorrhage |
0.6% |
| Coagulation Factor Viii Level Abnormal |
0.6% |
| Gastrointestinal Haemorrhage |
0.6% |
| Headache |
0.6% |
| Immune Tolerance Induction |
0.6% |
| Mouth Haemorrhage |
0.6% |
| Seasonal Allergy |
0.6% |
|
| Factor Viii Inhibition |
24.3% |
| Death |
8.1% |
| Haemorrhage |
8.1% |
| Hiv Infection |
8.1% |
| Loss Of Consciousness |
8.1% |
| Tremor |
8.1% |
| Dyspnoea |
4.1% |
| Hepatitis B Surface Antigen Positive |
4.1% |
| Accidental Overdose |
2.7% |
| Haemarthrosis |
2.7% |
| Incorrect Product Storage |
2.7% |
| Muscle Haemorrhage |
2.7% |
| Pyrexia |
2.7% |
| Therapeutic Product Contamination |
2.7% |
| Throat Tightness |
2.7% |
| Wrong Technique In Drug Usage Process |
2.7% |
| Anti Factor Viii Antibody Positive |
1.4% |
| Chronic Hepatic Failure |
1.4% |
| Drug Hypersensitivity |
1.4% |
| Drug Ineffective |
1.4% |
|
| Secondary |
| Factor Viii Deficiency |
42.7% |
| Haemarthrosis |
15.0% |
| Haemophilia |
11.9% |
| Prophylaxis |
7.1% |
| Traumatic Haemorrhage |
7.1% |
| Factor Viii Inhibition |
3.6% |
| Hypertension |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Immune Tolerance Induction |
2.0% |
| Gastrointestinal Haemorrhage |
1.2% |
| Cerebral Haemorrhage |
0.8% |
| Bleeding |
0.4% |
| Haemorrhage |
0.4% |
| Headache |
0.4% |
| Hemophilia A |
0.4% |
| Mouth Haemorrhage |
0.4% |
| Seasonal Allergy |
0.4% |
|
| Factor Viii Inhibition |
38.2% |
| Loss Of Consciousness |
21.7% |
| Tremor |
11.8% |
| Hiv Test False Positive |
4.6% |
| Seroconversion Test Positive |
4.6% |
| Device Related Infection |
2.6% |
| Haemarthrosis |
2.6% |
| Sepsis |
2.6% |
| Hepatitis B Surface Antigen Positive |
2.0% |
| Somnolence |
2.0% |
| Head Injury |
1.3% |
| Inguinal Hernia Repair |
1.3% |
| Dyspnoea |
0.7% |
| Gynaecomastia |
0.7% |
| Nausea |
0.7% |
| Otitis Externa |
0.7% |
| Thrombosis |
0.7% |
| Urinary Bladder Haemorrhage |
0.7% |
| Vision Blurred |
0.7% |
|
| Concomitant |
| Hiv Infection |
44.7% |
| Acquired Immunodeficiency Syndrome |
12.6% |
| Diabetes Mellitus |
8.3% |
| Factor Viii Deficiency |
7.6% |
| Hepatitis C |
4.4% |
| Haemophilia |
3.7% |
| Panic Disorder |
3.5% |
| Drug Use For Unknown Indication |
1.9% |
| Hypertension |
1.9% |
| Weight Decreased |
1.9% |
| Haemarthrosis |
1.4% |
| Prophylaxis |
1.2% |
| Reflux Oesophagitis |
1.2% |
| Renal Failure Acute |
1.2% |
| Haemorrhage Prophylaxis |
0.9% |
| Product Used For Unknown Indication |
0.9% |
| Diarrhoea |
0.8% |
| Epididymitis |
0.8% |
| Abdominal Pain |
0.7% |
| Abdominal Pain Upper |
0.7% |
|
| Varices Oesophageal |
13.4% |
| Renal Failure Acute |
11.0% |
| Platelet Count Decreased |
8.5% |
| Lumbar Vertebral Fracture |
7.3% |
| Haemorrhage |
6.1% |
| Melaena |
4.9% |
| Nausea |
4.9% |
| Spinal Compression Fracture |
4.9% |
| Thrombocytopenia |
4.9% |
| Tonic Convulsion |
4.9% |
| Jaundice |
3.7% |
| Reflux Oesophagitis |
3.7% |
| Renal Failure |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Dysgeusia |
2.4% |
| Factor Viii Inhibition |
2.4% |
| Herpes Zoster |
2.4% |
| Hyperlipidaemia |
2.4% |
| Joint Swelling |
2.4% |
| Lymphoma |
2.4% |
|
